Amicus Therapeutics, Inc. (FOLD)

Apr 27, 2026 - FOLD was delisted (reason: acquired by BMRN)

14.49

0.00 (0.00%)

Inactive · Last trade price on Apr 24, 2026

Amicus Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	634.21	634.21	528.3	399.36	329.23	305.51
Revenue Growth	20.05%	20.05%	32.29%	21.30%	7.76%	17.11%
Gross Profit	561.28	561.28	475.35	362.03	290.63	271.05
Operating Income	32.79	32.79	24.88	-77.21	-212.12	-206.43
Net Income	-19.3	-27.11	-56.11	-151.58	-236.57	-250.46
Earnings Per Share	-0.09	-0.09	-0.18	-0.51	-0.82	-0.92
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Galafold	521.7	521.7	458.05	387.78	329.05	305.51
Pombiliti and Opfolda	112.51	112.51	70.24	11.58	0.19	-
Revenue (Total)	634.21	634.21	528.3	399.36	329.23	305.51

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	293.54	293.54	249.95	286.2	293.6	482.5
Total Debt	442.36	442.36	443.64	445.06	452.12	440.13
Net Cash (Debt)	-148.83	-148.83	-193.7	-158.86	-158.53	42.37
Net Cash Growth	-	-	-	-	-	1.99%
Net Cash Per Share	-0.48	-0.48	-0.64	-0.54	-0.55	0.16

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	33.15	33.15	-33.89	-69.09	-166.58	-202.49
Capital Expenditures	-3.3	-3.3	-3.55	-7.44	-3.77	-3.88
Free Cash Flow	29.85	29.85	-37.44	-76.53	-170.34	-206.38
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	88.50%	88.50%	89.98%	90.65%	88.28%	88.72%
Operating Margin	5.17%	5.17%	4.71%	-19.33%	-64.43%	-67.57%
Pretax Margin	0.03%	0.03%	-5.44%	-37.59%	-73.52%	-79.06%
Profit Margin	-4.27%	-4.27%	-10.62%	-37.96%	-71.85%	-81.98%
FCF Margin	4.71%	4.71%	-7.09%	-19.16%	-51.74%	-67.55%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	39.70	59.68	87.63	-	-	-
P/FCF Ratio	152.43	148.29	-	-	-	-
PS Ratio	7.17	6.98	5.33	10.43	10.43	10.54